Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients

Kidney transplant recipients (KTRs) are at an increased risk of hospitalization, complications, and mortality from COVID-19 compared with the general population.1Akalin E. Azzi Y. Bartash R. et al.Covid-19 and kidney transplantation.N Engl J Med. 2020; 382: 2475-2477Crossref PubMed Scopus (594) Google Scholar, 2Hartzell S. Bin S. Benedetti C. et al.Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients.Am J...